v3.25.4
Share Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Awards
The following table presents a summary of the Company’s unvested restricted stock awards:
Number of
Shares
Weighted-
Average Grant
Date Fair Value
(In thousands)
Unvested restricted stock awards outstanding at January 1, 202318$18.93 
Granted54$13.85 
Vested(18)$18.93 
Forfeited / Canceled—$— 
Unvested restricted stock awards outstanding at December 31, 202354$13.85 
Granted65$13.20 
Vested(65)$13.76 
Forfeited / Canceled—$— 
Unvested restricted stock awards outstanding at December 31, 202453$13.17 
Granted67$10.94 
Vested (1)(53)$13.17 
Forfeited / Canceled—$— 
Unvested restricted stock awards outstanding at December 31, 202567$10.94 
Totals may not sum or recalculate due to rounding
____________________

(1)     The aggregate intrinsic value of restricted stock that vested during 2025 was approximately $0.6 million based on the stock price at the time of vesting.
The following table presents a summary of the Company’s unvested restricted stock units:
Number of
Units
Weighted-
Average Grant
Date Fair Value
(In thousands)
Unvested restricted stock units outstanding at January 1, 2023252$5.93 
Granted79$15.13 
Vested(175)$4.33 
Forfeited / Canceled(18)$11.50 
Unvested restricted stock units outstanding at December 31, 2023138$12.51 
Granted96$13.14 
Vested(81)$10.85 
Forfeited / Canceled—$— 
Unvested restricted stock units outstanding at December 31, 2024153$13.78 
Granted109$11.48 
Vested (1)(61)$13.92 
Forfeited / Canceled—$— 
Unvested restricted stock units outstanding at December 31, 2025201$12.50 
Totals may not sum or recalculate due to rounding
____________________

(1)     The aggregate intrinsic value of restricted stock units that vested during 2025 was approximately $0.7 million based on the stock price at the time of vesting.
The following table presents a summary of the Company's performance share units:
Number of
Units
Weighted-
Average Grant
Date Fair Value
(In thousands)
Unvested performance share units outstanding at January 1, 202317$13.51 
Granted19$15.31 
Vested(17)$13.51 
Forfeited / Canceled(3)$15.31 
Unvested performance share units outstanding at December 31, 202316$15.31 
Granted23$13.63 
Vested(16)$15.31 
Forfeited / Canceled—$— 
Unvested performance share units outstanding at December 31, 202423$13.63 
Granted44$11.60 
Vested (1)(23)$13.63 
Forfeited / Canceled—$— 
Unvested performance share units outstanding at December 31, 202544$11.60 
Totals may not sum or recalculate due to rounding
____________________

(1)     The aggregate intrinsic value of performance share units that vested during 2025 was approximately $0.3 million.
Schedule of Weighted Average Assumptions
The fair value of stock options was estimated on the date of the grant using a Black-Scholes valuation model that used the weighted average assumptions noted in the following table. Expected volatility is based on historical volatility of the Company’s common stock and other factors. The Company uses historical data on the exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock-based payments granted. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. Generally, stock options granted to employees and directors vest ratably over three years from the grant date and expire seven years from the date of grant. There were no stock options granted during the years ended December 31, 2025, 2024 or 2023.

AssumptionsYear Ended December 31, 2021
Risk-free interest rate0.79%
Expected dividend yield—%
Expected volatility78.2%
Expected term5 years
Schedule of Stock Option Activity The following table presents a summary of the Company's stock option activity:
Number of SharesWeighted Average Exercise Price per ShareWeighted Average Remaining Contractual Term(years)Aggregate Intrinsic Value (in millions)
(In thousands)
Outstanding at January 1, 2023286$— 7.64$2.38 
Granted—$— — $— 
Exercised(36)$15.68 — $— 
Expired—$— — $— 
Forfeited / Canceled—$— — $— 
Outstanding at December 31, 2023250$— 7.66$1.02 
Exercisable at December 31, 2023100$— 7.66$0.41 
Outstanding at December 31, 2023250$— 7.66$1.02 
Granted—$— — $— 
Exercised—$— — $— 
Expired—$— — $— 
Forfeited / Canceled—$— — $— 
Outstanding at December 31, 2024250$— 6.65$0.53 
Exercisable at December 31, 2024150$— 6.65$0.32 
Outstanding at December 31, 2024250$— 6.65$0.53 
Granted—$— — $— 
Exercised—$— — $— 
Expired—$— — $— 
Forfeited / Canceled—$— — $— 
Outstanding at December 31, 2025250$— 5.65$1.21 
Exercisable at December 31, 2025200$— 5.65$0.97 
Totals may not sum or recalculate due to rounding
____________________

(1)     All outstanding stock options as of December 31, 2025 are expected to vest.
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The following tables summarize the Company's share and incentive-based compensation (in thousands):
Recurring Compensation Expense (1)
Year Ended December 31, 2025
Equity-classified awards:
Restricted stock awards and units$1,909 
Performance share units535 
Stock options300 
Total share-based compensation expense$2,744 
Year Ended December 31, 2024
Equity-classified awards:
Restricted stock awards and units$1,790 
Performance share units264 
Stock options300 
Total share-based compensation expense$2,354 
Year Ended December 31, 2023
Equity-classified awards:
Restricted stock awards and units$1,415 
Performance share units229 
Stock options301 
Total share-based compensation expense$1,945 
____________________

(1)Included in general and administrative expense in the accompanying consolidated statements of operations.